# Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

> **NCT00713154** · PHASE2 · TERMINATED · sponsor: **Mitos Pharmaceuticals** · enrollment: 16 (actual)

## Conditions studied

- Alopecia

## Interventions

- **DRUG:** MTS-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00713154
- **Lead sponsor:** Mitos Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2007-09
- **Final completion:** 2008-09
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Major planned study protocol modifications
- **Last updated:** 2008-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713154, "Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00713154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*